FDA Drug Recalls

Recalls / Class I

Class ID-0311-2024

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

Up&Up brand dry eye relief (Carboxymethylcellulose 0.5%) packaged in 0.5 FL OZ (15 mL) each bottles (Twin Pack), Distributed by: Target Corporation Minneapolis, MN 55403, NDC 76168-800-30

Affected lot / code info
All lots

Why it was recalled

Non-Sterility

Recalling firm

Firm
Kilitch Healthcare India Limited
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
R - 904 905 T T C Industrial Road, Navi Mumbai, N/A, India

Distribution

Quantity
137,544 bottles
Distribution pattern
Nationwide within the United States

Timeline

Recall initiated
2023-11-13
FDA classified
2024-02-05
Posted by FDA
2024-02-14
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0311-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.